Pritelivir

DB11844InvestigationalSmall molecule

Pritelivir has been used in trials studying the prevention of HSV-2 and Genital Herpes.

Chemical structure of Pritelivir
Formula / weight
C18H18N4O3S2 · 402.49 g/mol (avg)
Code names
AIC-316

Resolves to

Compound
UNII07HQ1TJ4JECAS348086-71-5ChEMBLCHEMBL4069597PubChem491941
Structure
InChIKeyIVZKZONQVYTCKC-UHFFFAOYSA-NSMILESCN(C(=O)CC1=CC=C(C=C1)C1=CC=CC=N1)C1=NC(C)=C(S1)S(N)(=O)=O
Targets
P00915CA1P00918CA2
Transporters
P08183ABCB1Q9UNQ0ABCG2

What you can answer from here — as of September 24, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
2TransportersSubstrate / inhibitor direction, not just membership
Listed above
14Drug interactionsStructured to mechanism, not free text
Sign in
7Clinical trialsPhase, status and sponsor resolved per trial
Sign in
10+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Pritelivir, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In